| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.0087 | 0.9 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.9 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |